October 31, 2018

IntegriChain’s David Weiss to Speak on Government Pricing at Pharma Industry Conference scwish:pharma

Philadelphia, PA, October 31, 2018 – IntegriChain, a leading life sciences commercial analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence, today announced that Executive Director of Solutions, David Weiss, will speak on government pricing at the scwish:pharma Conference. The scwish:pharma conference is designed for pharmaceutical manufacturers seeking actionable guidance about major industry issues and opens tomorrow in Boca Raton, FL.

Weiss’ presentation, “Critical Profitability and Compliance Considerations in Government Price Reporting,” will address best practices for creating government pricing efficiencies, an important challenge for commercialization teams to overcome. Weiss will speak on the key impact of generics and brand pricing decisions on government price reporting and future profitability and compliance, and he will review government payer trends that affect commercializing products.

“Government pricing requirements are incredibly complex with complicated calculations and confusing regulations, and many manufacturers find it overwhelming,” said Weiss. “At schwish:pharma, I will help clarify recent regulatory changes that are important and provide some insight into what pharmaceutical executives need to know about potential changes be on the horizon that could have long-term impact.”

About IntegriChain
IntegriChain is a life sciences commercial analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence. Our ICyte Platform and solutions uniquely focus on what happens after the patient and provider commit to therapy. More than 140 life science manufacturers rely on insights delivered from IntegriChain’s data, analytics, and managed services to drive strategic decision-making and on-going business management across their payers, specialty pharmacies, patient services, and distribution channel partners. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA; the Access Management Operations center is in Ambler, PA; and the Patient Services Center is in Atlanta, GA. For more information, visit www.integrichain.com or follow us on Twitter @IntegriChain and LinkedIn.

Contact
Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com